Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction

Published:2010-07 Issue:5 Volume:56 Page:392-406
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kramer Daniel G.,Trikalinos Thomas A.,Kent David M.,Antonopoulos George V.,Konstam Marvin A.,Udelson James E.

Funder

Tufts Clinical and Translational Science Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference145 articles.

1. Ventricular remodeling in heart failure: a credible surrogate end point;Konstam;J Card Fail,2003

2. Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?;Kalra;Int J Cardiol,2002

3. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial;Anand;Lancet,2004

4. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL);Mann;Circulation,2004

5. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE);Packer;Circulation,2002

Cited by 398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol-driven approach to guideline-directed medical therapy optimization for heart failure: A real-world application to recovery;American Heart Journal Plus: Cardiology Research and Practice;2024-09

2. Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction;International Journal of Cardiology;2024-08

3. Effect of henagliflozin on left ventricular mass index in dialysis patients with HFpEF (HELD-HF): protocol for a multicentre, randomised, double-blind, placebo-controlled trial;BMJ Open;2024-08

4. High-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE RCT;Efficacy and Mechanism Evaluation;2024-08

5. Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure;Journal of the American College of Cardiology;2024-08